Domestic manufacturers maintained leading positions in analgesics in Romania in 2013, due to the traditional usage of lower-priced products. Zentiva SA, previously named Sicomed SA, maintained its outright lead in 2013, reaching a share of 21% in value terms. The company's most popular brands are Acetylsalicylic Acid, Ibalgin, Antinevralgic P and Paracetamol, together with Algocalmin, which switched to Rx in 2011.
Value sales of analgesics at constant 2013 prices are expected to achieve a CAGR of 3% over the forecast period, benefiting from the existing strong level of self-medication in Romania and intense advertisement as either specifically targeted or systemic drugs. Both adult and paediatric analgesics are expected to exhibit similar growth patterns.
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Romania with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Romania, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Romania market research report includes:
Our market research reports answer questions such as:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent market research methodology, conducted in-country
Reasons to Get this Report
- What is the market size of Analgesics in Romania?
- What are the major brands in Romania?
- Are combination products with acetaminophen still popular?
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Analgesics is strongly represented in OTC in Romania and self-medication trends play an important role in consumption. Sales of analgesics, in current value terms, accounted for 30% of the total sales of OTC products in Romania in 2013. An 11% rise in value sales of combination products in 2013 boosted the performance of overall analgesics. A switch of dipyrone/metamizol to Rx medication in 2011/2012 was partially responsible for the weaker performance of dipyrone even in 2013. Overall, sales of analgesics slowed down in 2013, increasing by 8% in value terms after rising by 12% in 2012.
ANALGESICS IN ROMANIA
LIST OF CONTENTS AND TABLES
Table 1 Sales of Analgesics by Category: Value 2008-2013
Table 2 Sales of Analgesics by Category: % Value Growth 2008-2013
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2008-2013
Table 4 NBO Company Shares of Analgesics: % Value 2009-2013
Table 5 LBN Brand Shares of Analgesics: % Value 2010-2013
Table 6 Forecast Sales of Analgesics by Category: Value 2013-2018
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2013-2018
Biofarm SA in Consumer Health (romania)
Summary 1 Biofarm SA: Operational Indicators
Summary 2 Biofarm SA: Competitive Position 2013
Labormed Pharma SA in Consumer Health (romania)
Summary 3 Labormed Pharma SA: Operational Indicators
Summary 4 Labormed Pharma SA: Competitive Position 2013
Zentiva SA in Consumer Health (romania)
Summary 5 ZENTIVA SA: Operational Indicators
Summary 6 Zentiva SA: Competitive Position 2013
Steady Growth of Consumer Health Assured Despite Economic Crisis
Higher Margins on OTC Products Motivate Chemists/pharmacies To Sell Them
Lower Prices Ensure Competitiveness of Domestic Products
Speciality Stores for Herbal/traditional Products Expand Rapidly
Self-medication Products Have Strong Growth Potential
Key Trends and Developments
Increasing Health-consciousness of the Population Ensures Good Potential for OTC
Expanding Pharmacy Network in Rural Regions Helps OTC To Expand
Herbal/traditional Products Preferred To Standard OTC Medicine
Doctors' and Chemists' Advice Is the Most Efficient Marketing Channel
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2008-2013
Table 9 Life Expectancy at Birth 2008-2013
Table 10 Sales of Consumer Health by Category: Value 2008-2013
Table 11 Sales of Consumer Health by Category: % Value Growth 2008-2013
Table 12 NBO Company Shares of Consumer Health: % Value 2009-2013
Table 13 LBN Brand Shares of Consumer Health: % Value 2010-2013
Table 14 Distribution of Consumer Health by Format: % Value 2008-2013
Table 15 Distribution of Consumer Health by Format and Category: % Value 2013
Table 16 Forecast Sales of Consumer Health by Category: Value 2013-2018
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2013-2018
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Summary 7 OTC: Switches 2010-2013
Summary 8 Research Sources
This report does not have a list of Companies Mentioned available
This report does not have a press release associated with it